Stockscreener 앱 받기
2.83
23.31%
-0.86
시간 외 거래:
2.82
-0.01
-0.35%
전일 마감가:
$3.69
열려 있는:
$2.9
하루 거래량:
3.21M
Relative Volume:
5.35
시가총액:
$196.97M
수익:
$299.48M
순이익/손실:
$-86.45M
주가수익비율:
-1.8867
EPS:
-1.5
순현금흐름:
$-17.32M
1주 성능:
-19.60%
1개월 성능:
-29.95%
6개월 성능:
-50.35%
1년 성능:
-62.52%
1일 변동 폭
$2.80
$3.2098
1주일 범위
$2.80
$3.88
52주 변동 폭
$2.80
$9.24
Health Catalyst Inc Stock (HCAT) Company Profile
명칭
Health Catalyst Inc
전화
801-708-6800
주소
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
HCAT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
2.83 | 265.88M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
282.13 | 46.19B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
60.87 | 9.61B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
66.58 | 10.89B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
93.05 | 7.86B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
34.59 | 5.92B | 906.14M | -52.62M | 89.62M | -0.3621 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-17 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-04-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2025-01-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2024-01-03 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-12-13 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-11-13 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-05-10 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-05-10 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | 개시 | Stephens | Equal-Weight |
| 2023-04-04 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-10-31 | 개시 | Wells Fargo | Equal Weight |
| 2022-10-25 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-08-05 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-04-14 | 개시 | Guggenheim | Buy |
| 2022-03-17 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2021-12-02 | 개시 | Jefferies | Hold |
| 2021-10-14 | 개시 | BTIG Research | Buy |
| 2021-04-29 | 재개 | JP Morgan | Overweight |
| 2020-12-08 | 개시 | Berenberg | Buy |
| 2020-07-14 | 개시 | Citigroup | Buy |
| 2020-06-18 | 개시 | Stifel | Buy |
| 2020-06-15 | 재개 | Evercore ISI | Outperform |
| 2020-05-15 | 개시 | Guggenheim | Buy |
| 2020-04-21 | 개시 | RBC Capital Mkts | Outperform |
| 2020-04-13 | 개시 | SVB Leerink | Outperform |
| 2020-04-02 | 개시 | Canaccord Genuity | Buy |
| 2019-12-20 | 개시 | Raymond James | Strong Buy |
| 2019-10-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-08-19 | 개시 | Evercore ISI | Outperform |
| 2019-08-19 | 개시 | Goldman | Buy |
| 2019-08-19 | 개시 | JP Morgan | Overweight |
| 2019-08-19 | 개시 | Piper Jaffray | Overweight |
| 2019-08-19 | 개시 | SVB Leerink | Outperform |
| 2019-08-19 | 개시 | SunTrust | Buy |
| 2019-08-19 | 개시 | William Blair | Outperform |
모두보기
Health Catalyst Inc 주식(HCAT)의 최신 뉴스
Wells Fargo Raises PT on Health Catalyst, Inc. (HCAT); Maintains ‘Buy’ Rating - MSN
Health Catalyst, Inc. (NASDAQ:HCAT) Just Reported Earnings, And Analysts Cut Their Target Price - uk.finance.yahoo.com
Slammed 30% Health Catalyst, Inc. (NASDAQ:HCAT) Screens Well Here But There Might Be A Catch - 富途牛牛
Health Catalyst Second Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Health Catalyst Q2 2025 Earnings Call Highlights: Revenue Exceeds Guidance, Restructuring Efforts Underway - AInvest
Health Catalyst Shares Fall After 2025 Revenue Guidance Cut, CEO to Step Down in June 2026 - 富途牛牛
Health Catalyst (HCAT): Navigating Medicaid Cuts and Strategic Restructuring to Unlock Long-Term Value - AInvest
Health Catalyst HCAT Stock Drops 21.5% on Weak Revenue GuidanceNews and Statistics - IndexBox
Why Health Catalyst (HCAT) Stock Is Down Today - Yahoo Finance
Health Catalyst's Leadership Transition and Financial Outlook: Navigating Short-Term Volatility for Long-Term Resilience - AInvest
Health Catalyst tanks after FY revenue outlook cut, Cantor downgrade - Seeking Alpha
Earnings call transcript: Health Catalyst Q2 2025 results show significant EPS miss - Investing.com
Health Catalyst stock downgraded by Cantor Fitzgerald amid revenue concerns - Investing.com Nigeria
Health Catalyst Inc (HCAT) Q2 2025 Earnings Call Highlights: Navigating Growth Amid Funding ... - Yahoo Finance
Health Catalyst Reports Strong Q2 2025 Results - TipRanks
Health Catalyst Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Transcript : Health Catalyst, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
Health Catalyst (HCAT) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Health Catalyst: Q2 Earnings Snapshot - San Antonio Express-News
Longtime Health Catalyst CEO to step down - Modern Healthcare
Health Catalyst earnings missed by $0.63, revenue topped estimates - Investing.com Canada
Health Catalyst (NASDAQ:HCAT) Posts Q2 Sales In Line With Estimates But Stock Drops - TradingView
Health Catalyst CEO Dan Burton to step down effective June 2026 - TipRanks
Health Catalyst CEO Dan Burton to step down in June 2026 - Investing.com Australia
Health Catalyst reports Q2 adjusted EPS 4c, consensus 4c - TipRanks
Health Catalyst CEO Retirement Announcement - TipRanks
Health Catalyst CEO Exits at Peak: 1,100 Clients, $2.2B in Healthcare Improvements - Stock Titan
Health Catalyst Reports Second Quarter 2025 Results - The Manila Times
Health Catalyst Financial Results Announcement: What to ExpectNews and Statistics - IndexBox
Health Catalyst (HCAT) Reports Q2: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Health Catalyst HCAT 2025Q2 Earnings Preview Upside Potential with Projected Revenue Growth - AInvest
Unity, Domo, Five9, Health Catalyst, and Shopify Shares Skyrocket, What You Need To Know - MSN
Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt? - simplywall.st
Why is Health Catalyst Inc. stock attracting strong analyst attentionFind the best stocks for sustainable growth - Jammu Links News
What analysts say about Health Catalyst Inc. stockUnlock your portfolio’s hidden potential - Jammu Links News
Is Health Catalyst Inc. stock overvalued or undervaluedCapitalize on fast-moving stock trends - Jammu Links News
Is Health Catalyst Inc. a growth stock or a value stockDiscover breakthrough stocks with expert help - Jammu Links News
How does Health Catalyst Inc. generate profit in a changing economySuperior trading gains - Jammu Links News
What are Health Catalyst Inc. company’s key revenue driversHigh-velocity capital appreciation - Jammu Links News
What are analysts’ price targets for Health Catalyst Inc. in the next 12 monthsFree Investment Community - Jammu Links News
What catalysts could drive Health Catalyst Inc. stock higher in 2025Maximize your returns with expert insights - Jammu Links News
What are the latest earnings results for Health Catalyst Inc.Superior risk-adjusted returns - Jammu Links News
Health Catalyst Announces Q2 2025 Operating Results and Conference Call for August 7, 2025 - AInvest
Screener Results Flag Health Catalyst Inc. as OversoldScalable Portfolio Growth Suggestions Released - beatles.ru
Volume Surge May Signal Institutional Interest in Health Catalyst Inc.Watchlist for Smart Swing Trading Updated - metal.it
New Product Launches: Will They Boost Health Catalyst Inc. Stock in 2025Consistent Income Focused Trade List Analyzed - metal.it
Why Health Catalyst Inc. stock attracts strong analyst attentionReal Trader Watchlist of Hot Stocks Released - beatles.ru
Health Catalyst Inc (HCAT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.97%
6.08%
자본화:
|
볼륨(24시간):